Search criteria | ||||
Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study | ||||
"Kerstin M G Brand, Laura Saarelainen, Jaak Sonajalg, Emmanuelle Boutmy, Caroline Foch, Marja Vääräsmäki, Laure Morin-Papunen, Judith Schlachter, CLUE Study Group, Katja M Hakkarainen, Pasi Korhonen CLUE Study Group: Minna Vehkala, Robyn Thorén, Henrik Svanström " | ||||
"Leading author: Kerstin Brand: Merck KGaA, Darmstadt, Germany IQVIA author affiliations: Global Database Studies, IQVIA, Espoo, Finland; Global Database Studies, IQVIA, Tartu, Estonia; Global Database Studies, IQVIA, Solna, Sweden; Global Database Studies, IQVIA" | ||||
BMJ Open Diab Res Care 2022;10:e002363. doi:10.1136/bmjdrc-2021-002363 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://drc.bmj.com/content/10/1/e002363.full | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Obesity | 2022 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective cohort analysis | |
A novel decision model to predict the impact of weight management interventions: The Core Obesity Model. | ||||
Sandra Lopes 1, Henrik H Meincke 1, Mark Lamotte 2, Anamaria-Vera Olivieri 3, Michael E J Lean 4 | ||||
1Novo Nordisk A/S Søborg Denmark. 2IQVIA Zaventem Belgium. 3IQVIA Basel Switzerland. 4Human Nutrition School of Medicine, Dentistry and Nursing Royal Infirmary University of Glasgow Glasgow UK. | ||||
Obesity Science & Practice 2021. https://doi.org/10.1002/osp4.495 |
||||
, Article | ||||
, Belgium, Switzerland | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34123394 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Obesity | 2021 | English | , Clinical setting: Primary care, Cost effectiveness | |
External Validation of the Core Obesity Model to Assess the Cost Effectiveness of Weight Management Interventions | ||||
Sandra Lopes 1, Pierre Johansen 2, Mark Lamotte 3, Phil McEwan 4, Anamaria-Vera Olivieri 5, Volker Foos 4 | ||||
1Novo Nordisk A/S, Søborg, Denmark. snlb@novonordisk.com. 2Novo Nordisk A/S, Søborg, Denmark. 3IQVIA, Zaventem, Belgium. 4Health Economics and Outcomes Research Ltd, Cardiff, UK. 5IQVIA, Basel, Switzerland. | ||||
Pharmacoeconomics 2020 https://doi.org/10.1007/s40273-020-00941-3 + Pharmacoeconomics. 2021 Jan;39(1):137-138. doi: 10.1007/s40273-020-00982-8. Epub 2020 Nov 30 |
||||
, Article | ||||
, Belgium, Denmark, Switzerland, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32656686/ | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Obesity | 2020 | English | , Clinical setting: Primary care, Cost effectiveness | |
Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada | ||||
Sean Wharton1, Aiden Liu2, Arash Pakseresht2, Emil N?rtoft3, Christiane L. Haase3, Johanna Mancini4, G. Sarah Power5, Sarah Vanderlelie1, and Rebecca A. G. Christensen1 | ||||
1 Wharton Medical Clinic, Burlington, Canada. Correspondence: Sean Wharton (wharton@whartonmedicalclinic.com) 2 Novo Nordisk Canada Inc., Mississauga, Canada 3 Novo Nordisk A/S, S?borg, Denmark 4 IQVIA, Kirkland, Canada 5 IQVIA, Mississauga, Canada. | ||||
Obesity (Silver Spring). 2019 Jun;27(6):917-924. doi: 10.1002/oby.22462. Epub 2019 May 7. |
||||
, Article | ||||
, Canada, Nordic | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31062937 | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2019 | English | ||
Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada | ||||
1. Sean Wharton Wharton Medical Clinic, Burlington, ON, Canada 2. Aiden R Liu Novo Nordisk Canada, Mississauga, ON, Canada 3. Arash Pakseresht Novo Nordisk Canada, Mississauga, ON, Canada 4. Emil Nørtoft Novo Nordisk A/S, Copenhagen, Denmark 5. Christiane L Haase Novo Nordisk A/S, Copenhagen, Denmark 6. Johanna Mancini IQVIA, Montreal, QC, Canada 7. G Sarah Power IQVIA, Mississauga, ON, Canada 8. Sarah VanderLelie Wharton Medical Clinic, Burlington, ON, Canada 9. Rebecca AG Christensen Wharton Medical Clinic, Burlington, ON, Canada | ||||
1. Sean Wharton Wharton Medical Clinic, Burlington, ON, Canada 2. Aiden R Liu Novo Nordisk Canada, Mississauga, ON, Canada 3. Arash Pakseresht Novo Nordisk Canada, Mississauga, ON, Canada 4. Emil Nørtoft Novo Nordisk A/S, Copenhagen, Denmark 5. Christiane L Haase Novo Nordisk A/S, Copenhagen, Denmark 6. Johanna Mancini IQVIA, Montreal, QC, Canada 7. G Sarah Power IQVIA, Mississauga, ON, Canada 8. Sarah VanderLelie Wharton Medical Clinic, Burlington, ON, Canada 9. Rebecca AG Christensen Wharton Medical Clinic, Burlington, ON, Canada | ||||
ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://imsbrogancapabilities.com/pdf/rwe/nn-ispor-poster-may-2018.pdf | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2018 | English | , Retrospective cohort analysis | |
Excess Healthcare Resource Utilization in Obesity Pharmacotherapy Candidates in Canada | ||||
Feroz T1, Charland K2, Heembrock S2, Borrelli R2, Skovgaard R1 | ||||
1 NovoNordisk Canada Inc. Canada 2 IMS Brogan Canada | ||||
13th International Conference on Obesity, 2016, May 1-4, Vancouver, Canada |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/obesity-conference-poster-2016.pdf | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Obesity | 2016 | English | , Retrospective cohort analysis | |
Body mass index and all-cause mortality in patients with hypertension | ||||
Xu W, Shubina M, Goldberg SI & Turchin A | ||||
Harvard Medical School, Boston | ||||
Obesity (Silver Spring) 23(8):1712-20 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/26179058 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Obesity | 2015 | English | , Retrospective database analysis | |
Effect of adjustable gastric banding on quality of life and weight loss in the Helping Evaluate Reduction in Obesity (HERO) registry study: 2-year analysis | ||||
Lao W-L, Malone DC, Armstrong EP, Voellinger D, Somers S, Jin J, Dreyer N, Globe D | ||||
Current Medical Research & Opinion 2015: Posted on-line July 8, 2015. doi: 10.1185/03007995.2015.1059802 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2015 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Prevalence of Comorbidities and Baseline Characteristics of LAP-BAND AP® Subjects in the Helping Evaluate Reduction in Obesity (HERO) Study | ||||
Dreyer NA, Dixon JB, Okerson T, Finkelstein EA, Globe D | ||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2013 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Safety Assessment of an Anti-Obesity drug (Sibutramine) | ||||
Tyczynski JE1,Oleske DM2, Klingman D3 Ferrufino CP4, Lee WC4 | ||||
1 Astellas Pharma, Northbrook, IL,USA 2 Abbott Laboratories, Abbott, IL, USA 3 Gainsville, VA, USA 4 IMS Health, Falls Church, VA, USA | ||||
Drug Safety 2012;35(8):629-644 |
||||
, Article | ||||
, Germany, UK | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2012 | English | , Retrospective cohort analysis | |
Obesity and the risk of psoriatic arthritis: a population-based study. | ||||
Love TJ, Zhu Y, Zhang Y, Wall-Burns L, Ogdie A, Gelfand JM, Choi HK. | ||||
Landspitali University Hospital Department of Science, Education, and Innovation | ||||
Ann Rheum Dis. 2012 Aug;71(8):1273-7. doi: 10.1136/annrheumdis-2012-201299. Epub 2012 May 14. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22586165 | ||||
Condition | Year | Language | Analysis type | |
, Obesity, Orthopedics, Rheumatology | 2012 | English | , Retrospective database analysis | |
OC-038 Healthcare use according to body mass index (BMI) category in individuals registered to GP practices | ||||
Ashman K E , Cawood A L & Stratton R J | ||||
Nutricia Medical affairs | ||||
Gut2012;61:A16-A17 doi:10.1136/gutjnl-2012-302514a.38 |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://gut.bmj.com/content/61/Suppl_2/A16.3 | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2012 | English | , Retrospective database analysis | |
Body mass index and obstructive sleep apnoea in the UK: a cross-sectional study of the over-50s. | ||||
Wall H, Smith C & Hubbard R. | ||||
NHS Improvement | ||||
Prim Care Respir J. 2012 Dec;21(4):371-6. doi: 10.4104/pcrj.2012.00053. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22751736 | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Obesity | 2012 | English | , Retrospective database analysis | |
BMI and obstructive sleep apnoea in the UK: a crosssectional study of the over-50s | ||||
Wall H, Smith C & Hubbard R | ||||
NHS Improvement | ||||
Primary Care Respiratory Journal 10.4104/pcrj.2012.00053 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22751736 | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2012 | English | , Retrospective database analysis | |
Helping Evaluate Reduction in Obesity: Characterizing Patients who Choose LAP-BAND in the HERO Observational Study | ||||
Dixon JB, Finkelstein EA, Dreyer N, Menon V, Globe D, Okerson T | ||||
the 29th Annual Meeting of the American Society for Metabolic and Bariatric Surgery. June 2012; San Diego, CA |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2012 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Assessing real-world European patient profiles in the Helping Evaluate Reduction in Obesity (HERO) study [abstract] | ||||
Dixon JB, Dreyer N, Finkelstein EA, Su Z, Globe D, Okerson T | ||||
EuroPrevent. Dublin, Ireland, May 2012 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2012 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Waist Circumference and Body Mass Index Recording – A Thin Database | ||||
Thompson M, Hards M & Blak BT | ||||
Cegedim | ||||
14th Annual European Congress (ISPOR) ISPOR, 2011, Madrid |
||||
, Poster | ||||
, UK | ||||
Abstract: http://65.54.113.239/Publication/49552658/psy57-waist-circumference-and-body-mass-index-recording-a-thin-database-study | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous, Obesity | 2011 | English | , Retrospective database analysis | |
Cross-cultural comparisons of the overweight/obese population in the US and Europe | ||||
Annunziata K, Gupta S, Chapnick J, Pokras S, Klingman D | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Diagnosis and treatment flows for morbidly obese patients visiting physician offices in the US | ||||
Pokras S1, Klingman D1, Tierce J1 | ||||
1 IMS Health, Falls Church, VA, US | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Poor health care behaviors among overweight individuals: opportunities for physician intervention. | ||||
Pokras SM1, Klingman D1, Annunziata K, Gupta S, Chapnick J, Tierce JC1 | ||||
1 IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA, US 3 Consumer Health Sciences Princeton, NJ, US 4 Consumer Health Sciences Princeton, NJ, US 5 Consumer Health Sciences Princeton, NJ, US 6 IMS Health, Falls Church, VA, US | ||||
Journal of General Internal Medicine 2008;23 (suppl 1, April); Poster presented at the 31st Annual Meeting of the Society of General Internal Medicine, Pittsburgh, PA, April 10, 2008 Society of General Internal Medicine (SGIM) 31st Annual Meeting. Pittsburgh, PA, April 2008. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Epidemiological study, Retrospective database analysis | |
Utilization & Patient Experience with Obesity Prescriptions in the US. | ||||
S Pokras1, D Klingman1, K Annunziata, J Chapnick, J Tierce1 | ||||
1 IMS Health, Falls Church, VA, US | ||||
24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ISPE), Copenhagen, Denmark. August 19, 2008 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Factors Associated With Prescription Of Obesity Medications In The US. | ||||
S Pokras1, D Klingman1, J Tierce1 | ||||
1 IMS Health, Falls Church, VA,US | ||||
24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ISPE), Copenhagen, Denmark. August 19, 2008. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Utilization & Patient Experience with Obesity Prescriptions in the US. | ||||
S Pokras, D Klingman, K Annunziata, J Chapnick, J Tierce. | ||||
IMS Health; Consumer Health Sciences | ||||
24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ISPE), Copenhagen, Denmark. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Factors Associated With Prescription Of Obesity Medications In The US. | ||||
S Pokras, D Klingman, J Tierce | ||||
IMS Health | ||||
24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ISPE), Copenhagen, Denmark. August 19, 2008. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
Poor health care behaviors among overweight individuals: Opportunities for physician intervention. | ||||
Pokras SM, Klingman D, Annunziata K, Gupta S, Chapnick J, Tierce J. | ||||
IMS Health, Consumer Health Sciences | ||||
Society of General Internal Medicine (SGIM) 31st Annual Meeting, Pittsburgh, PA: |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
The incidence rate of seizures in relation to BMI in UK adults. | ||||
Gao S, Juhaeri J & Dai WS | ||||
Global Pharmacovigilance and Epidemiology, Sanofi-Aventis, Bridgewater, New Jersey | ||||
Obesity (Silver Spring). 2008 Sep;16(9):2126-32. doi: 10.1038/oby.2008.310. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19186334 | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Neurological disorders, Obesity | 2008 | English | , Retrospective database analysis | |
Long-term cost-effectiveness of rimonabant in Germany | ||||
Pirk O1, Hessel F2, Kotowa W1, Hertel N1 | ||||
1 IMS Health, Nuremberg, Germany 2 Sanofi Aventis Deutschland, Berlin, Germany | ||||
ISPOR 10th Annual European Congress, 20-23 October 2007, Dublin, Irel Value in Health 10 (6): A 414 |
||||
, Abstract, Oral presentation | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2007 | English | , Cost effectiveness | |
Clinical management and economic impact of cardiovascular risk factors monitoring in obese and overweight patients in primary care | ||||
Polanco Sánchez C, Franch Nadal J, Layola Brias M, Lara Suriñach N | ||||
Revista Española de EconomÃa de la Salud 2007;6(8):436-46 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2007 | Spanish | , Market impact | |
Costs of premature death attributed to obesity in Spain. | ||||
Echevarria A, Betegón L, Badia X. | ||||
ISPOR 11th Annual International Meeting. Philadelphia, Pennsylvania (USA) |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2006 | English | , Burden of illness | |
Diagnosis and treatment flows for morbidly obese patients visiting physician offices in the US | ||||
Pokras SM, Klingman D, Tierce JC | ||||
Value in Health 2008;11,3 (May/June);Poster presented at the 13th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Toronto, Ontario, Canada, May 3-7, 2008 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2006 | English | , Retrospective database analysis | |
Long-term cost-effectiveness of zoledronic acid versus risedronate in patients with Paget's disease of the bone in Germany | ||||
Kurth AA1 , Kotowa W2, Goel D3, Maiwenn JA4 | ||||
1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands | ||||
ECCEO 6, 2006, March 15-18, Vienna, Austria |
||||
, Oral presentation | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2006 | English | , Cost effectiveness | |
Zoledronic acid in the long-term management of Paget's disease of the bone in Germany - a cost savings approach? | ||||
Kurth AA1, Kotowa W2, Fricke F-U2, Quednau K3, Maiwenn JA4 | ||||
1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands | ||||
ISPOR 9th Annual International Congress, 29-31 October 2006, Copenhagen, Denmark |
||||
, Oral presentation | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2006 | English | , Cost effectiveness | |
Zoledronic acid in the long-term management of Paget's disease of the bone in Germany - a cost savings approach? | ||||
Kurth AA1, Kotowa W2, Fricke F-U2, Quednau K3, Maiwenn JA4 | ||||
1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands | ||||
Value in Health 2006, 9(6) |
||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2006 | English | , Cost effectiveness | |
Long-term cost-effectiveness of zoledronic acid versus risedronate in patients with Paget's disease of the bone in Germany | ||||
Kurth AA1 , Kotowa W2, Goel D3, Maiwenn JA4 | ||||
1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands | ||||
ECCEO 6, 2006, March 15-18, Vienna, Austria |
||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2006 | English | , Cost effectiveness | |